Buscar
Mostrando ítems 21-30 de 204
Dispositivos en falla cardíacaDevices in Patients with Heart Failure. Cardiac Resynchronization Therapy
(Universidad de Antioquia, Facultad de MedicinaMedellín, Colombia, 2021)
Global mortality variations in patients with heart failure : Results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study
(2017-07-01)
Background Most data on mortality and prognostic factors in patients with heart failure come from North America and Europe, with little information from other regions. Here, in the International Congestive Heart Failure ...
Interactions between ß 1 and ß 2 adrenergic receptor polymorphisms as risk factors for chronic heart failure Interacción entre los polimorfismos del receptor ß 1 y ß 2 adrenérgico como predictor de riesgo de insuficiencia cardiaca crónica
(2008)
Background: ß adrenergic receptors (AR) are highly polymorphic and important regulators of cardiovascular homeostasis. Among these, ß1 and ß2 AR regulate cardiac contractility and frequency and are important pharmacological ...
NO modulation of carotid body chemoreception in health and disease
(Elsevier, 2012)
Nitric oxide (NO), at physiological concentrations, is a tonic inhibitory modulator of carotid body (CB)
chemosensory discharges. NO modulates the chemoreception process by several mechanisms, indirectly
by modifying the ...
Síndrome de Twiddler: reporte de un casoTwiddler´s syndrome: report of a case
(Universidad de Antioquia, Facultad de MedicinaMedellín, Colombia, 2021)
Pleiotropic effects of atorvastatin in heart failure: Role in oxidative stress, inflammation, endothelial function, and exercise capacity
(ELSEVIER SCIENCE INC, 2008-04)
Background: Increased oxidative stress, a common feature in chronic heart failure, has been associated with inflammation, endothelial dysfunction, and extracellular matrix degradation. Statins have known anti-inflammatory ...
Mitochondria, myocardial remodeling, and cardiovascular disease
(2012)
The process of muscle remodeling lies at the core of most cardiovascular diseases. Cardiac adaptation to pressure or volume overload is associated with a complex molecular change in cardiomyocytes which leads to anatomic ...
Uric acid, xanthine oxidase and heart failure: Unresolved issues
(OXFORD UNIV PRESS, 2008-12)
Gln27→Gluβ2-adrenergic receptor polymorphism in heart failure patients: Differential clinical and oxidative response to carvedilol
(2009)
We investigated the clinical response of chronic heart failure patients with β2-adrenergic receptor Gln27→Glu polymorphism treated for 6 months with carvedilol, a α/β-antagonist with antioxidant properties. The 6-min. walk ...